EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+42.34%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$1.34B
AUM Growth
+$378M
(+40%)
Cap. Flow
+$131M
Cap. Flow
% of AUM
9.78%
Top 10 Holdings %
Top 10 Hldgs %
61.12%
Holding
70
New
18
Increased
13
Reduced
7
Closed
23
Top Buys
| 1 |
Oric Pharmaceuticals
ORIC
|
$89.1M |
| 2 |
Xencor
XNCR
|
$66.3M |
| 3 |
Avidity Biosciences
RNA
|
$59.5M |
| 4 |
AKUS
Akouos, Inc. Common Stock
AKUS
|
$44.5M |
| 5 |
Geron
GERN
|
$41.9M |
Top Sells
| 1 |
Arvinas
ARVN
|
$61.6M |
| 2 |
Fate Therapeutics
FATE
|
$59.1M |
| 3 |
Ironwood Pharmaceuticals
IRWD
|
$44.3M |
| 4 |
FibroGen
FGEN
|
$30.7M |
| 5 |
IPHA
Innate Pharma
IPHA
|
$29.8M |
Sector Composition
| 1 | Healthcare | 93.3% |
